Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 1-3 years of age~* Lives in study villages~Exclusion Criteria:~* Unable to drink 100 mL of sugar water~* Demonstrating evidence of severe acute malnutrition, WHZ \< or = -3, presence of bi-pedal pitting edema~* Apparent need for acute medical treatment for an illness or injury~* Parent refusal to participate and return for 7-week follow-up

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 3 Years
- Healthy Volunteers: t

Study Arms:
- Zinc therapy (Type: EXPERIMENTAL): High-dose zinc, equivalent 20 mg elemental zinc, to be given once per day for 14 days
- Albendazole (Type: EXPERIMENTAL): Albendazole to be given once on the day of enrollment. Placebo will then be given for 13 days following.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo will be given for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).